Archive for the Category ◊ Market ◊

Author:
• Friday, May 20th, 2011

Investing in a medical device company these days does not come cheap. Venture capitalists said at a panel during Thursday’s MedTech Investing Conference in Minneapolis that the cost and risk of bringing medical device start-ups to market has gotten so expensive, it has caused at least one of them to change their business model. Jan Garfinkle, [...]

Author:
• Friday, May 20th, 2011

In a letter to federal regulators yesterday, Carlsbad, CA-based AutoGenomics withdrew its filing for an initial public offering, which the company submitted in July, 2008. The company said at that time that its IPO would be made only by means of a prospectus, with J.P. Morgan Securities Inc. acting as the sole book-running manager of the offering. CEO [...]

Author:
• Monday, November 01st, 2010

Research & development programs are already being drastically scaled back. There are dwindling incentives to create new drugs and vaccines. And the full impact to the drug and medical devices sectors from the new health-care law is yet to be fully scoped out. FOX Business is taking a microscope to how health reform will affect [...]

Author:
• Sunday, October 24th, 2010

General Electric Co., the world’s biggest maker of medical-imaging equipment, agreed to buy cancer diagnostics company Clarient Inc. in a deal valued at about $580 million, speeding its expansion into tailored tests. A tender offer will begin at $5 for each common share and $20 for each preferred share of Aliso Viejo, California-based Clarient, the companies [...]

Author:
• Monday, October 18th, 2010

ST. PAUL, Minn. & PLYMOUTH, Minn.–(BUSINESS WIRE)– St. Jude Medical, Inc. (NYSE:STJ – News), a global medical device company, and AGA Medical Holdings, Inc. (Nasdaq:AGAM – News), today announced that the Boards of Directors of both companies have approved a definitive agreement under which St. Jude Medical will acquire all of the outstanding shares of [...]

Author:
• Wednesday, October 13th, 2010

Despite having to report the worst quarterly financial result since taking over Biomet, Jeff Binder was in a good mood, joking with analysts during his conference call with Wall Street analysts on October 12. Biomet did not have a good quarter. In fact it was an unexpectedly slow quarter. The company’s first quarter for 2011 [...]

Author:
• Thursday, August 19th, 2010

MEMPHIS, Tenn., Aug. 17 /PRNewswire-FirstCall/ — Medtronic Inc., (NYSE: MDT) and Osteotech, Inc., (Nasdaq: OSTE) today announced that the companies have signed a definitive agreement under which Medtronic will acquire Osteotech for $6.50 per share in cash for each share of Osteotech common stock. The total value of the transaction is expected to be approximately $123 million. Osteotech [...]

Author:
• Wednesday, July 14th, 2010

7/13/2010 DUBLIN–(BUSINESS WIRE)–Covidien (NYSE: COV – News), a leading global provider of healthcare products, today announced that it has completed the previously announced acquisition of ev3 Inc. for an aggregate consideration of approximately $2.6 billion, net of cash and short-term investments acquired. The tender offer expired at 12:00 midnight ET, at the end of July [...]

Author:
• Thursday, June 17th, 2010

DUBLIN & TROY, Mich.–(BUSINESS WIRE)–Covidien plc (NYSE: COV – News) and Somanetics Corporation (NASDAQ: SMTS – News) today announced that they have signed a definitive merger agreement under which Covidien will acquire all of the outstanding shares of Somanetics Corporation for $25.00 per share in cash, for a total of $250 million, net of cash [...]

Author:
• Friday, May 28th, 2010

* To sell Rigging Services business to Houston Wire & Cable * Says deal to reduce FY rev, profit * To focus on medical technology products May 27 (Reuters) – Diversified manufacturer Teleflex Inc (TFX.N) said it agreed to sell its rigging services business to Houston Wire & Cable (HWCC.O) for $50 million to focus [...]

Get Adobe Flash playerPlugin by wpburn.com wordpress themes